ZYDUS LIFESCIENCES
|
The Current P/E Ratio of ZYDUS LIFESCIENCES is 27.62.
Share Price | ₹1,051.9 | May 17,2024 |
Market Cap | ₹105,842.2 Cr | |
Earnings-TTM | ₹3,831.4 Cr | TTM-Consolidated Results |
Price/Earnings | 27.62x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of ZYDUS LIFESCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹105,842.2 Cr] as on May 17,2024
(/) Earnings [ ₹3,831.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 27.62x ]
Thus, for ZYDUS LIFESCIENCES , the investors are currently willing to pay 27.62 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ZYDUS LIFESCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ZYDUS LIFESCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of ZYDUS LIFESCIENCES
PE Ratio Performance Analysis for ZYDUS LIFESCIENCES
- ZYDUS LIFESCIENCES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 19.39x.
- ZYDUS LIFESCIENCES 's operated at median p/e ratio of 21.16x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ZYDUS LIFESCIENCES 's p/e ratio peaked in Mar2023 at 25.37x.
- ZYDUS LIFESCIENCES 's p/e ratio hit its five-year low in Mar2022 of 7.96x.
How does ZYDUS LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
ZYDUS LIFESCIENCES | 3,831.40 | 27.62 | 105,842.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.84 | 367,470.0 |
CIPLA LTD | 4,155.31 | 27.19 | 112,990.0 |
DR REDDYS LABORATORIES LTD | 5,563.20 | 17.39 | 96,742.1 |
DIVIS LABORATORIES LTD | 1,382.97 | 75.09 | 103,849.0 |
MANKIND PHARMA LTD | 1,926.55 | 43.54 | 83,873.0 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 61.13 | 91,321.0 |
LUPIN LTD | 1,935.57 | 38.91 | 75,312.7 |
AUROBINDO PHARMA LTD | 2,777.89 | 24.55 | 68,194.5 |
ABBOTT INDIA LTD | 1,201.22 | 46.86 | 56,289.8 |
ALKEM LABORATORIES LTD | 1,574.66 | 41.31 | 65,046.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ZYDUS LIFESCIENCES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.39x |
Max industry PE | 75.09x |
Median industry PE | 40.84x |
Average industry PE | 40.40x |
You may also like the below Video Courses